The polycomb group protein BMI-1 inhibitor PTC-209 is a potent anti-myeloma agent alone or in combination with epigenetic inhibitors targeting EZH2 and the BET bromodomains

類似資料

• EZH2 inhibition in multiple myeloma downregulates myeloma associated oncogenes and upregulates microRNAs with potential tumor suppressor functions
  著者:: Alzrigat, Mohammad, 等
  出版事項: (2016)
• Genome-wide profiling of histone H3 lysine 27 and lysine 4 trimethylation in multiple myeloma reveals the importance of Polycomb gene targeting and highlights EZH2 as a potential therapeutic target
  著者:: Agarwal, Prasoon, 等
  出版事項: (2016)
• Polycomb Target Genes Are Silenced in Multiple Myeloma
  著者:: Kalushkova, Antonia, 等
  出版事項: (2010)
• The miR-125a and miR-320c are potential tumor suppressor microRNAs epigenetically silenced by the polycomb repressive complex 2 in multiple myeloma
  著者:: Alzrigat, Mohammad, 等
  出版事項: (2017)
• A distinct metabolic response characterizes sensitivity to EZH2 inhibition in multiple myeloma
  著者:: Nylund, Patrick, 等
  出版事項: (2021)